Abstract
The aim of this study was to investigate the in vitro antithrombotic effects of two PAR1 antagonists, ER121958 and SCH203099 on both SFLLR-induced platelet adhesion and aggregation and on the thrombin time in human and guinea-pig platelets. ER121958 inhibited SFLLR-induced guinea-pig and human platelet adhesion with the IC(50) values of 1.73nM and 2.91nM, respectively and SFLLR-induced guinea-pig and human platelet aggregation with the IC(50) values of 2.74nM and 11.9nM, respectively. Similarly, SCH203099 exhibited a non competitive profile of inhibition on both SFLLR-induced guinea-pig and human platelet adhesion with the IC(50) values of 93nM and 127nM, respectively or SFLLR-induced guinea-pig and human platelet aggregation with the IC(50) values of 1.74microM and 2.36microM, respectively. These two antagonists failed to prolong the thrombin time. Altogether, these results highlighted the potent anti-platelets properties of both ER121958 and SCH203099 in an in vitro model of aggregation as well as in a static model of adhesion without any effect on the last step of coagulation cascade. Moreover, this work emphasized that guinea-pig is a suitable animal model to study the role of PAR1 antagonists since the magnitude of the eff...Continue Reading
References
Mar 22, 1991·Cell·T K VuS R Coughlin
Aug 15, 1995·European Journal of Biochemistry·S NystedtJ Sundelin
Dec 6, 1996·Journal of Medicinal Chemistry·M S BernatowiczS M Seiler
Apr 3, 1997·Nature·H IshiharaS R Coughlin
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·W F XuD C Foster
Aug 26, 1998·Nature·M L KahnS R Coughlin
Mar 17, 1999·The Journal of Clinical Investigation·M L KahnS R Coughlin
Feb 26, 2000·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·H NishikawaR Kuroda
May 23, 2000·Biochemistry·L CovicA Kuliopulos
Jun 6, 2000·The Journal of Biological Chemistry·M J ShapiroS R Coughlin
Sep 7, 2001·Nature·G R SambranoS R Coughlin
Nov 2, 2002·Nature Medicine·Zaverio M Ruggeri
Jan 31, 2003·Expert Opinion on Investigational Drugs·Claudia K DerianPatricia Andrade-Gordon
Aug 2, 2003·European Journal of Pharmacology·Yasuko KatoSeitaro Mutoh
Sep 13, 2003·Chest·Lawrence F Brass
Jun 15, 1995·Thrombosis Research·C K DerianP Andrade-Gordon
Mar 1, 2006·Circulation·Andrew J LegerAthan Kuliopulos
Jul 14, 2006·The Journal of Biological Chemistry·Michael HolinstatHeidi E Hamm
Aug 8, 2006·European Journal of Pharmacology·Chin-Chung Wu, Che-Ming Teng
Sep 6, 2006·Circulation·Andrew J LegerAthan Kuliopulos
Jan 4, 2007·The Journal of Biological Chemistry·Alexandra MazharianMarijke Bryckaert
Jan 5, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·David Varga-SzaboBernhard Nieswandt
Apr 7, 2009·European Journal of Pharmacology·Arnaud BocquetBruno Le Grand
May 30, 2009·Thrombosis Research·Robert LétienneBruno Le Grand
Jul 3, 2009·Thrombosis and Haemostasis·Victor L SerebruanyDeepak L Bhatt
Aug 5, 2009·Thrombosis and Haemostasis·Lisa K Jennings
Oct 10, 2009·The Journal of Biological Chemistry·Robin J MarjoramSamuel A Santoro
Citations
Jan 21, 2011·American Journal of Therapeutics·Jaya Prakash SugunarajChandrasekar Palaniswamy
May 15, 2012·International Journal of Radiation Oncology, Biology, Physics·Junru WangMartin Hauer-Jensen
Mar 26, 2016·Frontiers in Pharmacology·Qingrong QuGuoqiu Wu
Oct 25, 2012·Thrombosis and Haemostasis·Hannah Lee, Justin R Hamilton
Mar 6, 2012·Cellular Signalling·Esther LopezPedro C Redondo
Feb 11, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jin-Hong WangBai Kang
May 10, 2017·BioMed Research International·Chao YanKejing Ying
Mar 30, 2013·Stroke; a Journal of Cerebral Circulation·Junhao YanJohn H Zhang
Oct 29, 2013·MedChemComm·Jingjin ChenXiangshu Xiao